Navigation Links
EPA Approves XDS-CALUX(R) as Alternate Dioxin Test Method 4435
Date:5/30/2008

DURHAM, N.C., May 30 /PRNewswire/ -- Dr. George C. Clark of Xenobiotic Detection Systems (XDS) and Dr. Michael Denison at the University of California Davis, with support from the Superfund Basic Research Program, have developed a rapid and inexpensive recombinant cell bioassay system for the detection and relative quantification of dioxin-like chemicals. Dioxin-like chemicals are some of the most toxic chemicals known.

The CALUX(R) by XDS (Chemical Activated LUciferase Gene Expression) system has recently been published and is posted under "New Methods" on the SW-846 website. In March 2008, the EPA's Office of Solid Waste (OSW) Organic Methods Workgroup formally reviewed and approved Method 4435 for inclusion into Test Methods for Evaluating Solid Waste, Physical/Chemical Methods, also known as SW-846. The XDS-CALUX system consists of a unique sample processing method linked with a sensitive gene expression cell bioassay detection system providing unique sensitivity and selectivity for quantifying dioxin-like chemicals.

The XDS-CALUX(R) bioassay costs are 40%-70% lower than the traditional High Resolution Gas Chromatography/Mass Spectrometry (HR GC/MS) that was the old singular analysis standard. Xenobiotic Detection Systems Method 4435 provides an excellent screening tool to rapidly detect and quantify these ubiquitous and toxic environmental contaminants.

"This approval exemplifies the assay's versatility and is another major step for XDS," says President of XDS, Dr. George Clark. "Having been certified in the European Union since 2002 to primarily monitor feed and food it is wonderful to receive accreditation here in the U.S. Our screening analysis method is faster, far more affordable, and in many cases even more sensitive than the traditional HR GC/MS. The EPA's approval will allow us to better serve our clients and safeguard the environment from these toxic contaminants."

Research Institutes Worldwide using XDS-CALUX(R) Tech
'/>"/>

SOURCE Xenobiotic Detection Systems
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. FDA Approves Lillys Osteoporosis Drug EVISTA(R) (raloxifene HCl) to Reduce The Risk of Invasive Breast Cancer in Two Populations of Postmenopausal Women
2. Health Canada Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for HIV
3. FDA Approves Cymbalta(R) for Maintenance Treatment of Major Depressive Disorder
4. European Commission Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for Virologically Suppressed Adults With HIV-1 Infection
5. FDA Approves MiddleBrooks Amoxicillin PULSYS for Pharyngitis/Tonsillitis in Adolescents and Adults
6. FDA Approves XYZAL(R) (levocetirizine dihydrochloride) Oral Solution for the Relief of Seasonal and Year Round Allergies and Chronic Idiopathic Urticaria
7. UM Maryland Industrial Partnerships Program Approves 18 Collaborative Research Projects, Worth $4.4 Million, Between University Faculty, State Technology Companies
8. U.S. Food and Drug Administration Approves ABILIFY(R) (aripiprazole) for the Acute Treatment of Manic and Mixed Episodes Associated With Bipolar I Disorder in Pediatric Patients (10 to 17 Years of Age)
9. U.S. Food and Drug Administration Approves ORENCIA(R) (abatacept) for the Treatment of Moderate-to-Severe Polyarticular Juvenile Idiopathic Arthritis (JIA) in Patients Six Years and Older
10. FDA Approves HIFU Clinical Trial for Recurrent Prostate Cancer
11. Endoscopy Identified as Safe and Effective Method in Treating Common Complication of Gastric Bypass Surgery

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)..., DELFT,TheNetherlandsandJOHANNESBURG,November25...ionandPyxisDiscoveryannouncedtoday,thattheyhavesig...anies,services. , Pyxis,sworldclasscomputatio...dwithiThemba,sservicedivisiontoprovidemedicinaland...ughPyxis,internationalclientnetwork.iThembaPharma...
(Date:11/25/2009)..., MOUNTAINVIEW,Calif.,Nov.25/PRNewswire/-- Chem...ldatafromtheCompany,sPROTECT-1(theProspectiveRando...Traficet-EN(TM)(CCX282-B)inpatientswithmoderate-to...ithafavorablesafetyandtolerabilityprofile.Thestudy...onofdiseaseseverityasdefinedasa70-pointdecreaseint...
(Date:11/24/2009)..., PITTSBURGH,Nov.24/PRNewswire/-- ,, WHAT:Rom...rsfollowinganautoaccident,wasactuallyfullyconsciou...ingAmericasegment.TheDynaVoxEyeMaxwasfeaturedinthe...ndotherconditionscanunlockcommunication. ,, WHE...eonlineat www.dynavoxtech.com ,, WHO:Rom...
Breaking Medicine Technology:iThemba Pharmaceuticals (Pty) Ltd and Pyxis Discovery B.V. Announce Collaborative Agreement to Offer a Combined Service Offering 2ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 2ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 3ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 4ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 5DynaVox EyeMax Featured in Good Morning America Segment About Man Thought To Be in Coma for 23 Years 2Frost 26 Sullivan Sees Opportunities in Chinese Vaccine Industry 49561 1Frost 26 Sullivan Sees Opportunities in Chinese Vaccine Industry 49561 2Frost 26 Sullivan Sees Opportunities in Chinese Vaccine Industry 49561 3Study finds cancer is the second most frequent cause of death in individuals with schizophrenia 49558 1Study finds cancer is the second most frequent cause of death in individuals with schizophrenia 49558 2Give Life for the Fourth of July 49555 1Give Life for the Fourth of July 49555 2Give Life for the Fourth of July 49555 3
...Pivotal Trial Expected to Initiate in 2010 for Bli...(Nasdaq: MITI ), a biopharmaceutical company dev...tment of cancer, inflammation and autoimmune disea...inancial analysts at The Yale Club of New York Cit...t areas of development across Micromet,s BiTE anti...
...PITTSBURGH, April 23 invivodata inc., the ind...es (ePRO) solutions and services for global clinic... a certification program to provide the EXAcerbati...ts DiaryPRO(C) field-based ePRO system. , , The E...or evaluating the frequency, severity, and duratio...
Other Medicine Technology:Micromet Presents Update on BiTE Antibody Pipeline and Reviews Key AACR Presentations at R&D Day 2Micromet Presents Update on BiTE Antibody Pipeline and Reviews Key AACR Presentations at R&D Day 3Micromet Presents Update on BiTE Antibody Pipeline and Reviews Key AACR Presentations at R&D Day 4invivodata Certified to Deliver EXACT in COPD Trials 2invivodata Certified to Deliver EXACT in COPD Trials 3
(Date:11/25/2009)... fight rheumatoid arthritis, could help newly diag...AY, Nov. 25 (HealthDay News) -- A drug commonly us...arthritis now also shows some promise in helping p... The drug, rituximab (Rituxan), helped patients ke...h the disease had destroyed some of their pancreat...
(Date:11/25/2009)...ld lead mothers to overlook needed care, study fin...s) -- A mother,s depression can worsen her child,s...ix-month study of 262 black mothers and their chil...pressive symptoms had more frequent asthma symptom... symptoms had less frequent asthma symptoms. , ...
(Date:11/25/2009)... sees few signs of trouble with the H1N1 vaccine,... -- The ongoing H1N1 swine flu pandemic may be dri...younger patients, a U.S. health official said Wedn...pneumococcal infections around the country," Dr. A...Immunization and Respiratory Diseases at the U.S. ...
(Date:11/25/2009)...25/PRNewswire-USNewswire/--TheAmericanAssociationf...of2009,"S.2128,whichisdesignedtosubstantiallyimpro...re.ThebillwasintroducedbySen.GeorgeLeMieux(R-Fla.)...AmericanAssociationforHomecareoutlinedinits13-poin...oCongressinFebruary.Thoseprovisionsincludecallingf...
(Date:11/25/2009)...ncer vaccine carried into the body on a carefully ...to successfully eliminate tumors in mammals, scien...nslational Medicine . , The new approach, pionee...niversity, uses plastic disks impregnated with tum...to reprogram the mammalian immune system to attack...
Breaking Medicine News(10 mins):Health News:Type 1 Diabetes May Have a New Foe 2Health News:Type 1 Diabetes May Have a New Foe 3Health News:Mom's Depression May Worsen Child's Asthma 2Health News:Swine Flu Tied to Rise in Pneumonias Among Young 2Health News:Swine Flu Tied to Rise in Pneumonias Among Young 3Health News:Swine Flu Tied to Rise in Pneumonias Among Young 4Health News:American Association for Homecare Endorses New U.S. Senate Bill, the 'Prevent Health Care Fraud Act of 2009' 2Health News:Implant-based cancer vaccine is first to eliminate tumors in mice 2
...legal drugs has said that opium production in Afgh...rld Drug Report says over 90 percent of illegal op...anistan. According to a BBC report, the c...Afghanistan is unlikely to regain real security un...
...ity of California, have discovered that attaching...od cells dramatically increases the in vivo lifeti...cles are excellent carriers for delivering drugs. ...m one major limitation: they are quickly removed f...
...d Tuesday the rate of HIV/AIDS infections had drop...major challenge in the country. The state... rate fell from 6.1 percent in 2004 to the current...0 in 2005 as well as the drop in HIV prevalence fr...
...olecule found in the egg cells of the Northern Leo...ith the first drug treatment for brain tumours. ...oating found on a tumour cell and binds to its sur...ecular Biology, scientists from the University of ...
...the perception of noise in the ears or inside the ..., without any vibratory cochlear activity taking p...ced). It is estimated that between 10 and 17% of ...he symptom, the patient may have their everyday li...
...hat a substance derived from the bark of the South...er cells. The study, conducted at UT Sout...his substance could lead to a novel treatment for ...ed in a clinical trial to inspect its efficiency a...
Other Medicine News:Health News:Adherence of Nanoparticles to RBC- Very Effective Drug Delivery Method 2Health News:Brain Tumor Drug in Frogs A New Report 2Health News:Tinnitus Patients can Lead a Normal Life 2Health News:Tinnitus Patients can Lead a Normal Life 3Health News:Tinnitus Patients can Lead a Normal Life 4Health News:Tinnitus Patients can Lead a Normal Life 5Health News:Tree Bark Substance may Hold New Lung-cancer Treatment 2
Columbus Total Knee System
Shandon Humidity Chamber
Shandon Mini Hotplate
Shandon Histobath 2
Medicine Products: